De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Organon Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Organon heeft een totaal eigen vermogen van $144.0M en een totale schuld van $8.7B, wat de schuld-eigenvermogensverhouding op 6011.1% brengt. De totale activa en totale passiva bedragen respectievelijk $12.2B en $12.0B. De EBIT Organon is $1.3B waardoor de rentedekking 2.6 is. Het heeft contanten en kortetermijnbeleggingen van $704.0M.
Belangrijke informatie
6,011.1%
Verhouding schuld/eigen vermogen
US$8.66b
Schuld
| Rente dekkingsratio | 2.6x |
| Contant | US$704.00m |
| Aandelen | US$144.00m |
| Totaal verplichtingen | US$12.01b |
| Totaal activa | US$12.15b |
Recente financiële gezondheidsupdates
Recent updates
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Sep 19These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way
Sep 13
Organon & Co.: Cheap With Caveats
Aug 22Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
Aug 09Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price
Aug 07Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
Jul 30Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year
May 29Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals
May 10Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Organon: Thoughts Ahead Of Q3 Earnings
Oct 31Organon: What Is The Recipe?
Aug 31Oragenics announces early toxicology data for intranasal COVID-19 vaccine
Aug 24Organon, Samsung Bioepis Humira biosimilar Hadlima high concentration dosage gets FDA nod
Aug 17Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Aug 07Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $4.5B ) OGN } overtreffen de korte termijn passiva ( $2.8B ).
Langlopende schulden: De kortetermijnactiva van OGN ( $4.5B ) dekken de langetermijnschulden ( $9.3B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 5522.2% ) OGN wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van OGN is de afgelopen 5 jaar gestegen van 2.5% naar 6011.1%.
Schuldendekking: De schuld van OGN wordt niet goed gedekt door de operationele kasstroom ( 12.3% ).
Rentedekking: De rentebetalingen van OGN op haar schulden worden niet goed gedekt door EBIT ( 2.6 x dekking).